五年期
MyoD公司
生物
诱导多能干细胞
肌发生
细胞生物学
骨骼肌
胚泡
胚胎干细胞
心肌细胞
移植
胚胎
解剖
遗传学
胚胎发生
基因
内科学
医学
作者
Geun‐Ho Maeng,Satyabrata Das,Sarah M. Greising,Wuming Gong,Bhairab N. Singh,Stefan M. Kren,Daniel Mickelson,Erik Skie,Ohad Gafni,Jacob R. Sorensen,Cyprian Weaver,Daniel J. Garry,Mary G. Garry
标识
DOI:10.1038/s41551-021-00693-1
摘要
Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation. Human:pig embryos can be produced by deleting the MYF5, MYOD and MYF6 genes in pig embryos via CRISPR and somatic-cell nuclear transfer, followed by the delivery of TP53-null human induced pluripotent stem cells via blastocyst complementation.
科研通智能强力驱动
Strongly Powered by AbleSci AI